Molecular Microbiology Meeting 2018

MMM2018 Program minor changes
MMM2018 Program booklet
MMM2018 Feedback form


Please see below MMM presentations from speakers that have given permission. Some presentations contain unpublished data, therefore are not listed. We do hope to add more as we gain permissions.

Day 1 - 11th April 2018
Claire Gorrie
Amy Mathers
Matthew O'Sullivan
Karen Weynberg

Day 2 - 12th April 2018
Jeremy Barr
Rohan Beresford
Tara Djokic
Catriona Halliday
Muhammad Kamruzzaman
Sally Partridge
Linda Varadi

11-12 April, Waterview at Bicentennial Park, Sydney Olympic Park, NSW

Research | Current Practice | Frontier Technologies
Aim of the meeting; MMM provides a forum for research scientists, laboratory staff and clinicians to share the latest issues and developments in the field of molecular microbiology. It has become the principal forum for sharing new molecular diagnostics concepts in Australia. This two-day meeting uses an informal workshop style with encouragement for comments and questions from the floor. An exciting line up of speakers has been confirmed.
View program, members of ASM and ASA are eligible for a discounted registration view costs.

Call for posters

You're invited to submit an abstract to showcase your poster at MMM2018. A prize of $500 and 2-day registration to MMM2020 will be awarded.
Please send your abstract to, include your name, contact details, affiliations and abstract of 300 words max. Submission deadline 8th March 2018, if successful you will be notified by 15th March.

Co-chairing opportunities

Available to ECR's who have registered to attend MMM2018. If you're interested in co-chairing a session please send an to

The MMM2018 program includes sessions on

MMM2018 program

Click image to download

  • Emerging diagnostics
  • Bacteriophages
  • Synthetic biology
  • High-resolution imaging
  • Metagenomics and pathogen discovery
  • Real-time public health genomics
  • Antibiotic resistance
  • The microbiome

This meeting is ideal for biological scientists who see a translational aspect in the their research and for clinical scientists who need the most exciting new elements that biology and biotechnology have to offer.

Program committee; Jon Iredell, Ruby Lin, Jeremy Barr, Deborah Williamson, Andrew Ginn and Mitchell Brown